![](https://framerusercontent.com/images/wmV1TdWTwHYtEMunfkTN4G14bg.webp)
GOVERNANCE
Ensuring Transparency and Sustainable Growth
![](https://framerusercontent.com/images/wmV1TdWTwHYtEMunfkTN4G14bg.webp)
GOVERNANCE
Ensuring Transparency and Sustainable Growth
![](https://framerusercontent.com/images/wmV1TdWTwHYtEMunfkTN4G14bg.webp)
GOVERNANCE
Ensuring Transparency and Sustainable Growth
Young G. Shin
Professor, Chungnam National University, College of Pharmacy
Professor, Chungnam National University, College of Pharmacy
Dr. Young G. Shin is currently a Professor at the College of Pharmacy, Chungnam National University, South Korea. Dr. Shin began his career as an Investigator/Principal Scientist in the Drug Metabolism & Pharmacokinetics department at GlaxoSmithKline (Collegeville, PA, USA) before transitioning to the Drug Metabolism & Pharmacokinetics department at Genentech (South San Francisco, CA, USA). Dr. Shin’s main research areas include: 1). Development of fit-for-purpose bioanalytical/drug metabolism/ pharmacokinetics platforms for peptides, monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), ASOs, siRNAs and small molecules for the lead optimization stage and beyond. 2) Development of in silico ADME lead optimization processes and human PK/metabolism prediction platforms using QSAR and PBPK modeling etc. Dr. Shin is also the founder of Korea-PBSS, a member organization of the PBSS-International (CA, USA). Dr. Shin received BSc, MSc, and Ph.D. from the College of Pharmacy at Seoul National University in Seoul, South Korea, and completed his post-doctoral training at the College of Pharmacy, University of Illinois, Chicago (IL, USA).
Dr. Young G. Shin is currently a Professor at the College of Pharmacy, Chungnam National University, South Korea. Dr. Shin began his career as an Investigator/Principal Scientist in the Drug Metabolism & Pharmacokinetics department at GlaxoSmithKline (Collegeville, PA, USA) before transitioning to the Drug Metabolism & Pharmacokinetics department at Genentech (South San Francisco, CA, USA). Dr. Shin’s main research areas include: 1). Development of fit-for-purpose bioanalytical/drug metabolism/ pharmacokinetics platforms for peptides, monoclonal antibodies, bispecific antibodies, antibody-drug conjugates (ADCs), ASOs, siRNAs and small molecules for the lead optimization stage and beyond. 2) Development of in silico ADME lead optimization processes and human PK/metabolism prediction platforms using QSAR and PBPK modeling etc. Dr. Shin is also the founder of Korea-PBSS, a member organization of the PBSS-International (CA, USA). Dr. Shin received BSc, MSc, and Ph.D. from the College of Pharmacy at Seoul National University in Seoul, South Korea, and completed his post-doctoral training at the College of Pharmacy, University of Illinois, Chicago (IL, USA).